5 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2022–FY2023.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Ikcon Pharma Inc.'s own public LCA filings (FY2021–FY2023) — the same records an investigator pulls first.
Frequent amendments usually mean worksite or role changes; each one must be covered by a new LCA before the change takes effect.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 15% above the DOL prevailing wage across 5 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Ikcon Pharma Inc. sponsors H-1B workers, with 5 certified LCAs on file (FY2022–FY2023), including 4 in FY2023. The median certified salary is $75,629 (P25 $75,629, P75 $93,267). 100% of its certified filings meet or exceed the prevailing wage.
Ikcon Pharma Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2022–FY2023).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 40% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2022 | 1 | 0 | 0 | 1 |
| FY2023 | 4 | 0 | 0 | 4 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Drug Safety Specialist I-200-22293-542950 | $75,629/yr | II | Radnor, PA | Oct 20, 2022 | Certified |
Drug Safety Specialist I-200-22287-531405 | $93,267/yr | III | Radnor, PA | Oct 14, 2022 | Certified |
Drug Safety Associate I-200-22151-227331 | $72,634/yr | II | Phillipsburg, NJ | May 31, 2022 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2022–FY2023 disclosure records.
Most active filing months: Oct and May — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
2 states · 2 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →